Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Enfortumab Progresses As US Accelerated Approval Eyed In Urothelial Cancer

Jul 10 2018

• By Ian Haydock

Cancer cells on scientific background.3d illustration — ENFORTUMAB VEDOTIN MOVES AHEAD IN UROTHELIAL CANCER • Source: Shutterstock

Related Content

Breakthrough Status Arrives Late In Development Of Yervoy+Opdivo, Enfortumab Vedotin And Pedmark

Mar 30 2018

Keytruda's Broad Confirmatory Trials Suggest Evolution Of US FDA’s Accelerated Approval Model

Jun 21 2018

Related Companies

Astellas Pharma, Inc.

Seagen Inc.

Additional Topics

United States Clinical Trials Research & Development Cancer BioPharmaceutical

More from Anticancer

More from Therapeutic Category

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window